Description |
protein tyrosine phosphatase non-receptor type 11 |
kinase insert domain receptor |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Sorafenib
- Sunitinib
- 1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea
- Cediranib
- Vatalanib
- XL999
- TG-100801
- XL820
- CYC116
- Ramucirumab
- Pegdinetanib
- RAF-265
- ABT-869
- IMC-1C11
- Semaxanib
- Pazopanib
- Midostaurin
- Axitinib
- 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
- N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide
- N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide
- 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide
- N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE
- N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE
- 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one
- 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one
- N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
- N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
- N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
- Cabozantinib
- Regorafenib
- Ponatinib
- Lenvatinib
- Nintedanib
- Fostamatinib
- Erdafitinib
- Foretinib
- Ripretinib
- Pralsetinib
|
Diseases |
|
|
GWAS |
- Alcohol consumption (max-drinks) ( 29460428)
- Alcohol dependence symptom count ( 29460428)
- Apolipoprotein A1 levels ( 32203549)
- Blood pressure ( 21572416)
- Body mass index ( 26426971)
- Diastolic blood pressure ( 26390057)
- Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) ( 29455858)
- Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) ( 29455858)
- Glycated hemoglobin levels ( 34059833)
- HDL cholesterol levels ( 32203549)
- Hematological parameters ( 19820697)
- Hip circumference adjusted for BMI ( 34021172)
- Hypothyroidism ( 22493691)
- Low HDL-cholesterol levels ( 31006500)
- Mean arterial pressure ( 27618448)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (diuretics) ( 31015401)
- Medication use (thyroid preparations) ( 31015401)
- Multiple sclerosis ( 31604244)
- Peripheral artery disease ( 31285632)
- Platelet count ( 22139419 32888494)
- Reaction time ( 29844566)
- Response to alcohol consumption (flushing response) ( 29460428)
- Retinal vascular caliber ( 21060863)
- Rheumatoid arthritis ( 30423114 24390342)
- Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies) ( 30573655)
- Systolic blood pressure ( 26390057 30578418)
- Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) ( 29455858)
- Systolic blood pressure x smoking status (ever vs never) interaction (2df test) ( 29455858)
- Tetralogy of Fallot ( 23297363)
- Type 1 diabetes ( 17554300)
- Urate levels ( 23263486)
- Waist-to-hip ratio adjusted for BMI ( 34054925)
|
|
Interacting Genes |
173 interacting genes:
AATK
ACTN4
AKT1
AR
ARHGAP1
AXL
BCR
BDKRB2
BEX1
BEX2
BLZF1
BRAP
BTLA
CALR
CAT
CAV1
CBL
CCKBR
CD33
CDH5
CEACAM1
CHUK
CRKL
CSF2RB
CSF3R
CTDSP1
CTLA4
CXCR4
DAB1
DDR1
DMRTC1
EGFR
EPHA1
EPHA2
EPOR
ERBB2
ERBB3
ERBB4
FAM71E1
FBXW7
FCGR1B
FCGR2B
FCRL3
FGFR2
FGFR4
FLT1
FLT3
FLT4
FRS2
FRS3
FYN
GAB1
GAB2
GAB3
GHR
GMNN
GOLGA2
GRB2
GRIN2B
GTF2A2
HIP1R
HNRNPU
HSP90B1
HSPA5
HSPA9
HSPD1
IFNAR1
IFNGR1
IGF1R
IL4R
IL6ST
ILK
INPP5D
INSR
IRS1
IRS2
IRS4
JAK1
JAK2
KDR
KIR2DL5A
KIT
KLRC1
LAIR1
LCK
LEPR
LIFR
LILRB4
LINC01558
LINC02907
LNX1
LRP1
MAP3K4
MAP3K5
MAPK3
MAPT
MET
MPIG6B
MPL
MPZL1
MS4A2
MVK
MVP
NCOR2
NEB
NEDD9
NOX4
NRG3
NSUN5
NSUN5P2
NTRK1
NTRK2
ORMDL3
P2RX7
PAG1
PDGFRA
PDGFRB
PECAM1
PIK3CA
PIK3CG
PIK3R1
PILRA
PILRB
PLCG1
PNCK
POU2AF1
PRKCA
PRKCB
PRKCH
PRLR
PTK2
PTK2B
PTK7
PTPN6
PXN
RANGRF
RCOR3
RET
ROR2
ROS1
RPIA
SELE
SERF2
SERPINF1
SHC1
SIGLEC11
SIGLEC12
SIGLEC7
SIRPA
SIT1
SLAMF1
SLAMF6
SLC38A1
SLN
SOCS3
SOS1
SPRY2
SRC
SRSF10
STAT1
STAT3
STAT5A
STAT5B
SYNCRIP
TEK
TIE1
TLK1
TNFRSF1A
TREML1
TRIM32
TRMT2B
TSC2
TXNIP
|
68 interacting genes:
ACP1
AIMP2
ALB
ANXA5
ATR
BMX
BTRC
CACNA1S
CAV1
CBL
CCDC88A
CDH5
CHIC2
COL18A1
CRK
CSF2RB
CSNK1D
CTNNB1
DNM2
DUSP19
FBXO25
FBXW11
FLT1
FLT4
FRS2
FYN
GABARAP
GNA11
GNAQ
GRB10
GRB2
GSTA2
HSP90AA1
ILKAP
IQGAP1
ITGB3
KIT
MAPK1
NCK1
NRP1
P2RY2
PDCL3
PLCG1
PLCG2
PPM1A
PPM1B
PTPN11
PTPN12
PTPN6
PTPRR
RASA1
SERPINF1
SH2D2A
SHB
SHC1
SHC2
SHOX2
SRC
SRP72
STAT1
STYX
SYNGAP1
TIMP3
UTP3
VEGFA
VEGFC
VEGFD
YES1
|
Entrez ID |
5781 |
3791 |
HPRD ID |
01470 |
01867 |
Ensembl ID |
ENSG00000179295
|
ENSG00000128052
|
Uniprot IDs |
Q06124
|
P35968
|
PDB IDs |
2SHP
3B7O
3MOW
3O5X
3TKZ
3TL0
3ZM0
3ZM1
3ZM2
3ZM3
4DGP
4DGX
4GWF
4H1O
4H34
4JE4
4JEG
4JMG
4NWF
4NWG
4OHD
4OHE
4OHH
4OHI
4OHL
4PVG
4QSY
4RDD
5BK8
5DF6
5EHP
5EHR
5I6V
5IBM
5IBS
5X7B
5X94
5XZR
6ATD
6BMR
6BMU
6BMV
6BMW
6BMX
6BMY
6BN5
6CMP
6CMQ
6CMR
6CMS
6CRF
6CRG
6IHZ
6MD7
6MD9
6MDA
6MDB
6MDC
6MDD
6R5G
7JVM
7JVN
|
1VR2
1Y6A
1Y6B
1YWN
2M59
2MET
2MEU
2OH4
2P2H
2P2I
2QU5
2QU6
2RL5
2X1W
2X1X
2XIR
3B8Q
3B8R
3BE2
3C7Q
3CJF
3CJG
3CP9
3CPB
3CPC
3DTW
3EFL
3EWH
3KVQ
3S35
3S36
3S37
3U6J
3V2A
3V6B
3VHE
3VHK
3VID
3VNT
3VO3
3WZD
3WZE
4AG8
4AGC
4AGD
4ASD
4ASE
5EW3
5OYJ
6GQO
6GQP
6GQQ
6XVJ
6XVK
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|